Sal B reduces the incidence of squamous cell carcinoma (SCC) by inhibiting angiogenesis and decreasing the expression of hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) [68]. The gene discussed is VEGFA; the disease is squamous cell carcinoma.